Boston Scientific (BSX)

Operating Cash Flow Growth

5.69%

TTM · Period ending:

BSX logo

BSX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported5.69%
BSX TTM Cash from Operations YoY % (54.82% → 5.69%)
High-resolution chart · PNG

BSX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Boston Scientific Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-31.9378%
-12.9936%
-4.6452%
-4.9673%
57.4388%
117.4515%
200.3876%
544.4819%
748.2428%
650.5198%
220.4969%
1.2799%
-65.5096%
-71.7723%
-42.623%
25.6163%
1,400%
469.8997%
461.2%
141.0853%
-83.8019%
-61.1183%
-63.1268%
-41.0959%
8.1042%
9.3883%
3.0395%
11.1675%
25.4083%
43.7628%
54.8235%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.